- Investing Ideas
- /
- Materials Healthcare Sector
Materials Healthcare Sector
Results
2308
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,308 companies
Lantern Pharma
Market Cap: US$35.8m
Focuses on the discovery and development of oncology drug.
LTRN
US$3.32
7D
-19.2%
1Y
-43.0%
FibroBiologics
Market Cap: US$35.7m
Operates as a cell therapy, regenerative medicine company.
FBLG
US$0.93
7D
7.4%
1Y
-91.5%
Aligos Therapeutics
Market Cap: US$35.7m
A clinical-stage biopharmaceutical company, focuses on the development of novel therapeutics to address unmet medical needs in viral and liver diseases.
ALGS
US$5.84
7D
2.8%
1Y
-65.2%
Rafael Holdings
Market Cap: US$35.6m
Primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel.
RFL
US$1.43
7D
5.1%
1Y
-12.8%
InnoCan Pharma
Market Cap: CA$49.7m
A pharmaceutical technology company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Canada, Europe, and internationally.
INNO
CA$0.17
7D
6.3%
1Y
-41.4%
OS Therapies
Market Cap: US$35.5m
A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.
OSTX
US$1.64
7D
-3.5%
1Y
n/a
Institute of Biomedical Research
Market Cap: US$35.4m
Provides biomedical research and analytical services in Montenegro and internationally.
MRES
US$0.015
7D
-1.6%
1Y
102.2%
LTR Pharma
Market Cap: AU$55.2m
A biopharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia.
LTP
AU$0.28
7D
-17.6%
1Y
-22.2%
Microbix Biosystems
Market Cap: CA$49.3m
A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.
MBX
CA$0.35
7D
-5.4%
1Y
6.1%
Spectral AI
Market Cap: US$34.9m
An artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States.
MDAI
US$1.38
7D
1.5%
1Y
-25.0%
Provectus Biopharmaceuticals
Market Cap: US$34.9m
A clinical-stage biotechnology company, engages in developing immunotherapy medicines different diseases in the United States.
PVCT
US$0.083
7D
-5.4%
1Y
-56.3%
Annovis Bio
Market Cap: US$34.9m
A clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States.
ANVS
US$1.79
7D
15.5%
1Y
-79.5%
Estrella Immunopharma
Market Cap: US$34.7m
A clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States.
ESLA
US$0.96
7D
-6.0%
1Y
-8.7%
Precision Optics Corporation
Market Cap: US$34.7m
Designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States.
POCI
US$4.52
7D
-1.3%
1Y
-30.8%
Rockwell Medical
Market Cap: US$34.5m
Develops, manufactures, commercializes, and distributes various hemodialysis products for dialysis providers worldwide.
RMTI
US$1.01
7D
-2.9%
1Y
-43.9%
ANGLE
Market Cap: UK£25.8m
A medical diagnostic company, engages in developing cancer diagnostics products in the United Kingdom, Europe, North America, and internationally.
AGL
UK£0.08
7D
-3.0%
1Y
-62.4%
Golden Valley Development
Market Cap: US$34.2m
Through its subsidiaries, manufactures and markets patented products in the health care and home consumer markets sectors.
GVDI
US$0.05
7D
0%
1Y
n/a
Reliq Health Technologies
Market Cap: CA$47.3m
A healthcare technology company, develops secure telemedicine and virtual care solutions for the healthcare market.
RHT
CA$0.21
7D
0%
1Y
-57.0%
Iterum Therapeutics
Market Cap: US$34.1m
A pharmaceutical company, develops and commercializes treatments for drug resistant bacterial infections in Ireland, Bermuda, and the United States.
ITRM
US$0.99
7D
-2.4%
1Y
-32.0%
Propanc Biopharma
Market Cap: US$34.0m
A biopharmaceutical company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia.
PPCB
US$2.93
7D
6.4%
1Y
-92.5%
ZYUS Life Sciences
Market Cap: CA$46.6m
Manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada, the United States, Australia, and the European Union.
ZYUS
CA$0.61
7D
-12.9%
1Y
-41.3%
MedAdvisor
Market Cap: AU$52.0m
Provides pharmacy-driven patient engagement solutions in Australia, New Zealand, the United States, and the United Kingdom.
MDR
AU$0.087
7D
-12.1%
1Y
-72.8%
Tryptamine Therapeutics
Market Cap: AU$51.8m
A clinical-stage pharmaceutical development company, focuses on developing synthetic psilocybin-related molecules in Australia, Canada, Switzerland, and the United States.
TYP
AU$0.035
7D
0%
1Y
n/a
KDA Group
Market Cap: CA$46.2m
Provides technological solutions to general and specialized health sectors in Canada.
KDA
CA$0.25
7D
4.2%
1Y
-36.7%
Coeptis Therapeutics Holdings
Market Cap: US$33.0m
Operates as a biopharmaceutical company.
COEP
US$9.81
7D
-0.9%
1Y
47.5%
Radiopharm Theranostics
Market Cap: AU$51.3m
Engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs.
RAD
AU$0.022
7D
4.8%
1Y
-38.9%
LAVA Therapeutics
Market Cap: US$32.9m
Operates as a clinical-stage immuno-oncology company that focuses on developing cancer treatments.
LVTX
US$1.25
7D
-2.3%
1Y
-53.7%
Shield Therapeutics
Market Cap: UK£24.5m
A commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs.
STX
UK£0.024
7D
-12.6%
1Y
34.3%
Innovative MedTech
Market Cap: US$32.0m
Through its subsidiaries, engages in the provision of health and wellness services in the United States.
IMTH
US$0.60
7D
0%
1Y
-18.9%
NeuroSense Therapeutics
Market Cap: US$31.7m
A clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases in the United States and internationally.
NRSN
US$1.32
7D
20.0%
1Y
4.8%
NeuroOne Medical Technologies
Market Cap: US$31.5m
A medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States.
NMTC
US$0.67
7D
6.8%
1Y
-36.7%
Proteomics International Laboratories
Market Cap: AU$49.1m
Operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, India, and South East Asia.
PIQ
AU$0.36
7D
0%
1Y
-64.6%
Dyadic International
Market Cap: US$31.3m
A biotechnology platform company, develops, produces, and sells industrial enzymes and other proteins in the United States and internationally.
DYAI
US$1.04
7D
-5.5%
1Y
-35.6%
Theralase Technologies
Market Cap: CA$43.5m
A clinical stage pharmaceutical company, engages in the research, development, and commercialization of light activated photo dynamic compounds and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally.
TLT
CA$0.17
7D
-7.9%
1Y
9.4%
MariMed
Market Cap: US$31.1m
Engages in cultivation, production, and selling of branded cannabis products in the United States and internationally.
MRMD
US$0.08
7D
-6.1%
1Y
-68.1%
FibroGen
Market Cap: US$30.9m
A biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs.
FGEN
US$0.31
7D
0.2%
1Y
-74.5%